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EXPERIMENTAL STUDY
Vascular Smooth Muscle Proliferation
Synergistic Interaction Between Serotonin and Low Density Lipoproteins
Shinji Koba, MD,* Rajbabu Pakala, PHD, Takuya Watanabe, MD,* Takashi Katagiri, MD,*
Claude R. Benedict, MD, DPhil, FACC
Houston, Texas and Tokyo, Japan
OBJECTIVES The purpose of this study was to examine whether low density lipoproteins (LDLs) or mildly
oxidized LDL (mox-LDL) are mitogens for vascular smooth muscle cells (VSMCs) and
whether they can act synergistically with serotonin (5HT), a known mitogen for VSMC, in
potentiating the proliferative effect of 5HT on VSMC.
BACKGROUND Whether LDL or mox-LDL has a mitogenic effect on VSMC has been controversial. It is
possible that LDL may not be mitogenic to VSMC but modification of LDL may confer
mitogenic properties on LDL. A known mitogen for VSMC is 5HT that is released by
aggregating platelets at sites of atherosclerotic changes or endothelial dysfunction. It is
possible that LDL may interact with 5HT to enhance VSMC proliferation induced by 5HT.
METHODS Growth arrested primary VSMCs were incubated with different concentrations of LDL or
mox-LDL for 24 h followed by incubation with 5HT for another 24 h (mild oxidation of
LDL was achieved by incubating LDL with Cu11 which increased the thiobarbituric acid
product formation without a change in electrophoretic mobility). The increase in cell number
or the amount of 3H-thymidine incorporated into the DNA was then measured.
RESULTS Low density lipoprotein and mox-LDL induced significant VSMC proliferation by them-
selves and this effect was potentiated by 5HT. The 5HT2 receptor antagonist (LY281067)
and pertussis toxin reversed only the proliferative effect of 5HT. Polyinosinic acid (poly-I), an
inhibitor of scavenger receptors, did not inhibit the proliferative effect of LDL or mox-LDL
or their synergistic interaction with 5HT.
CONCLUSIONS These results suggest that LDL and mox-LDL act synergistically with 5HT in inducing
VSMC proliferation. The synergistic interaction could be blocked by LY281067 and pertussis
toxin but not by poly-I acid. (J Am Coll Cardiol 1999;34:1644–51) © 1999 by the American
College of Cardiology
Proliferation of intimal vascular smooth muscle cells
(VSMCs) is an important component in the development of
atherosclerosis and restenosis after angioplasty (1–3). Low
density lipoproteins (LDL) are the major cholesterol-
carrying lipoproteins, and the association between high
levels of plasma LDL and the development of atheroscle-
rosis is well-established. However, whether LDL directly
promotes the proliferation of VSMCs is controversial (4–
15). It is known that oxidative modification of LDL plays
an important role in the atherogenic process. Oxidation of
LDL is progressive, leading initially to the formation of
mildly oxidized LDL (mox-LDL) which is defined by a low
content of lipid peroxidation derivatives and little modifi-
cation in apolipoprotein B. Further modification leads to
the formation of oxidized LDL which contains high levels
of lipid peroxidation products and significant alterations in
apolipoprotein B (16–20). Highly oxidized LDL is known
to be cytotoxic for a variety of cells including VSMC,
whereas mox-LDL is a mitogen for vascular endothelial
cells and VSMCs (12–13,21). This suggests that the bio-
logical properties of mox-LDL may be different from those
of oxidized LDL (20).
The presence of both activated platelet aggregates and
lipoproteins in the atherosclerotic plaque suggests that both
may participate in the pathogenesis of the atherosclerotic
lesion formation (22). Activated platelets release various
mediators, including peptide growth factors such as beta-
thromboglubin and Platelet Derived Growth Factor from
alpha granules and nonpeptide products such as serotonin
(5HT), adenosine diphosphate and adenosine triphosphate
(22) from dense granules. Serotonin mediates vasoconstric-
tion and induces activation of other platelets, which may
promote the progression of coronary arterial diseases by
adhering to unstable atherosclerotic plaque(s) and initiating
thrombotic complications (23–25). Studies have shown that
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5HT is a mitogen for VSMCs (26–28), which may con-
tribute to the development of atherosclerotic lesions or
neointimal proliferation after vascular injury such as angio-
plasty. When atherosclerotic plaque ruptures, either as part
of natural progression of disease or after angioplasty,
VSMCs are exposed to flowing blood in circulation. Be-
cause platelets aggregate and release 5HT at the site of
injury, the interaction of 5HT with lipoprotein particles
from plasma may act in concert to stimulate the prolifera-
tion of arterial SMCs (29). In addition, both native and
oxidized LDL increase the releases of 5HT from platelets
and amplify 5HT-induced platelet aggregation at physio-
logic concentrations (22,23,25,30–32). Recent reports have
also shown that mox-LDL can induce platelet aggregation
and secretion (33). However, whether there is an interaction
between 5HT and LDL or mox-LDL on inducing VSMC
proliferation is unknown. In this study we report that LDL
and mox-LDL are mitogenic to VSMCs and they act
synergistically with 5HT in inducing VSMC proliferation.
MATERIALS AND METHODS
Materials. Serotonin (as creatine sulfate), bovine serum
albumin (BSA), insulin, transferrin, pargyline and pertussis
toxins were purchased from Sigma (St. Louis, Missouri).
The LY281067 was a gift from Eli Lilly Laboratories.
Serotonin was dissolved in 50 mM citrate buffer pH 5.5.
Dulbecco’s modified Eagle’s medium (DMEM), fetal bo-
vine serum (FBS) and phosphate buffered saline (PBS) was
purchased from Gibco BRL Life Technologies (Gaithers-
burg, Maryland). Trypsin ethylenediamine tetraacetic acid
(EDTA) and Hank’s balanced salt solution (HBSS) were
purchased from Sigma and 3H-thymidine (specific activity
20Ci/mol) was from Dupont NEN Research Products,
Boston, Massachusetts. Other reagents were purchased
from local vendors.
Arterial smooth muscle cell isolation. Rabbit primary
aortic VSMCs were isolated using the explant method (28).
The intima was first peeled off from the aorta and then the
media carefully stripped away from the adventia and placed
in a petri dish containing warmed HEPES-buffered
DMEM (37°C). The medial layer was cut into approxi-
mately 1 mm2 squares, which were transferred to a 25 cm2
tissue culture flask and barely covered with DMEM sup-
plemented with 20% FBS. The blocks of tissue were
cultured at 37°C in a humid atmosphere of 5% CO2 and
95% air (vol/vol). After three to four weeks the tissue blocks
were removed and the migrated VSMCs were cultured,
followed by subculture using trypsinization. The identity of
the VSMCs was confirmed by morphologic examination
and by staining for alpha-actin.
Isolation and preparation of LDL. Low density lipopro-
tein (density 1.019–1.063) was obtained from plasma con-
taining 1mM ethylenediamine tetraacetic acid (EDTA) by
density-gradient ultracentrifugation using the method of
Ferrei (34). Solid Kbr was used to adjust the density, and
centrifugation was carried out at 55,000 rpm for 15 h at 5°C
(Beckman 70.1 Ti rotor, Palo Alto, California). To mini-
mize variation in experimental results due to differences in
plasma donors, plasmas were pooled from several animals.
Isolated fractions were dialyzed at 4°C against PBS using
6,000 to 8,000 molecular weight cut off dialysis membrane
for 48 h and then concentrated under nitrogen using
Amicon concentrator with 10 KD cut off membrane.
Low density lipoprotein (1 to 2 mg/mL) was mildly
oxidized at 37°C in the presence of CuSO4 at a final
concentration of 5 mmol/L for 24 h. The oxidation was
terminated by the addition of EDTA (1.0 mmol/L, final
concentration). Minimally oxidized LDL fractions were
dialyzed against PBS with EDTA (0.1 mmol/L, final
concentration) and then concentrated in the same manner.
Experiments were carried out using physiologically rele-
vant (concentrations tested are found in circulation in
patients) and most commonly (experimentally) described
(20–200 mg/ml) concentrations of lipoproteins. Lipoprotein
concentrations are expressed as protein concentrations,
which were determined by the Bradford method using BSA
as standard (35). The purity and the extent of the oxidation
of LDL were determined by 1% agarose gel electrophoresis
and thiobarbituric acid reactive products (TBARS) forma-
tion. Thiobarbituric acid reactive products were measured
by mixing 100 mg of LDL or mox-LDL with 3 mL of
mixed solution consisting of 15% tricholoracetic acid,
0.375% thiobarbituric acid and 0.25 N hydrochloric acid.
This mixture was boiled for 15 min, centrifuged and the
absorbance of the supernatant measured at 532 nm using
tetramethoxy propane as a standard (36). Even at a concen-
tration of 10 mg/ml, native LDL had little or no effect on
TBARS. The mox-LDL had 29.9 6 2.6 pmol/mg protein
of TBARS formed, but it exhibited little or no change in the
electrophoretic mobility. The prepared LDL was used
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within 30 days of isolation. Lipoproteins were sterilized by
a 0.22 micron filter before use.
3H-thymidine incorporation. Primary VSMCs from first
or second passage were seeded into 35 mm diameter tissue
culture plates and grown to semiconfluence in DMEM
containing 10% FBS. Then, the growth medium was
replaced with 2 ml DMEM containing 0.1% FBS and was
incubated for approximately 72 h for growth arresting and
synchronization. The medium was then replaced with
DMEM supplemented with 500 mg/ml BSA, 10 mg/ml
bovine insulin, 20 mg/ml human transferrin, 25 ng/ml
selenium, 100 mmol/l parglyine and the indicted concentra-
tions of native LDL or mox-LDL. After 24 h of incubation,
the given concentrations of 5HT were added and incubated
for another 24 h. Tritiated thymidine at a concentration of
1 mCi/plate was added to the medium for the last 5 h. At
the end of this period the medium was removed, and the
plates were washed with ice-cold PBS. At that point, 6%
trichloroacetic acid was added to the cells, and the acid-
insoluble 3H-thymidine was collected on glass fiber filters.
The filters were washed with 100% ethanol and air dried,
and 3H-thymidine was quantified with a liquid scintillation
counter. All experiments were performed in quadruplicate
and each experiment was repeated a minimum of three
times.
Determination of VSMC number. Primary VSMCs from
first or second passage were seeded into a 35 mm diameter
plate at a density of 85,000 to 120,000 cells per plate in
DMEM containing 10% FBS. After 96 h, growth medium
was replaced with 2 ml DMEM containing 0.1% FBS and
incubated for approximately 72 h for arresting cell growth
and synchronization. Then, the medium was replaced with
DMEM supplemented with 500 mg/ml BSA, 10 mg/ml
bovine insulin, 20 mg/ml human transferrin, 25 ng/ml
selenium, 100 mmol/l pargyline and the indicated concen-
trations of native LDL or mox-LDL. After 24 h of
incubation, 50 mmol/L of 5HT was added and incubated
for another 24 h. The experiment was terminated by
aspiration of the medium, then the plates were washed with
PBS, and 0.5 ml of 2% (w/v) crude pancreatic trypsin in
Dulbecco’s PBS containing 152 mM EDTA was added to
each dish. The dishes were incubated at room temperature
for 2 min before the addition of 1.5 mL of serum. The
contents of each dish were diluted to 20 ml with Isotone II
(Coulter Electronics, Hialeah, Florida) and the cell number
was determined using a coulter counter. Triplicate counts
were taken for each plate and quadruplicates were used for
each determination.
Statistical analysis. Data are presented as mean 6 stan-
dard error (SE) and expressed as percentage change from
the baseline value for the unstimulated cells (5100%) except
for cell number. Data were analyzed by one way analysis of
variance (ANOVA) and the Bonferroni/Dunn test was used
to identify differences among the groups when the overall F
statistics were significant.
RESULTS
Effects of LDL and mox-LDL on 3H-thymidine incor-
poration by VSMC. The effect of increasing concentra-
tions of LDL or mox-LDL on 3H-thymidine incorporation
into DNA of VSMC is shown in Figure 1. Both LDL and
mox-LDL induced significant proliferation of VSMCs
(’1.2- or 2-fold increase in thymidine incorporation, re-
spectively, over the control; p , 0.05). In contrast to native
LDL, mox-LDL at a concentration as low as 20 mg/ml
induced a significant proliferation of VSMC. At concentra-
tions greater than 20 mg/ml, mox-LDL had a significantly
greater proliferative effect on VSMC when compared with
native LDL. At high concentrations (.250 mg/mL) both
LDL and mox-LDL were cytotoxic to VSMC (data not
shown).
Effect of 5HT on VSMC preincubated with LDL. The
interaction between increasing concentrations of LDL and
5HT on 3H-thymidine incorporation into DNA of VSMC
is shown in Figure 2. Serotonin alone at an added concen-
tration of 5 mM and 50 mM induced 3H-thymidine incor-
poration by 188 6 11% (259 6 21 cpm to 478 6 28 cpm)
and 211 6 11% (254 6 21 cpm to 534 6 28 cpm),
respectively (p , 0.05 compared with the baseline value).
Effect of 5HT on VSMC preincubated with mox-LDL.
The interaction between increasing concentrations of mox-
LDL and 5HT on 3H-thymidine incorporation into DNA
Figure 1. Effect of LDL and mox-LDL on 3H-thymidine incor-
poration into VSMC. The amount of 3H-thymidine incorporation
into DNA was determined in synchronized VSMCs stimulated
with indicated concentrations of LDL or mox-LDL in serum free
medium for 48 h. One hundred percent equals the baseline value
for 3H-thymidine incorporation into DNA (268 6 12 cpm).
Values shown are mean 6 standard error. LDL 5 low density
lipoprotein; mox-LDL 5 mildly oxidized low density lipoprotein;
VSMC 5 vascular smooth muscle cell. n 5 24; *p , 0.01
compared with control; **p , 0.001 compared with control.
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of VSMC is shown in Figure 3. In contrast to native LDL,
in the presence of mox-LDL both the concentrations of
5HT tested (5 mM and 50 mM) significantly increased
3H-thymidine incorporation into VSMC when compared
with the corresponding values with 5HT alone. Although
mox-LDL (120 mg/ml) alone increased 3H-thymidine in-
corporation by 100% (280 6 19 cpm to 567 6 26 cpm),
5 mM and 50 mM 5HT alone induced 3H-thymidine
incorporation by 100% (280 6 19 cpm to 560 6 14 cpm)
and 140% (280 6 19 cpm to 672 6 14 cpm), respectively,
over the control. However, the addition of 5 mM and
50 mM 5HT to VSMC preincubated with 120 mg/ml of
mox-LDL resulted in a 306 6 25% and a 453 6 54%
increase in 3H-thymidine incorporation over the control,
respectively (Fig 3).
Effect of LDL or mox-LDL and 5HT on VSMC num-
ber. To determine whether the induction of DNA synthe-
sis by LDL, mox-LDL or 5HT resulted in an increase in
cell number, we also examined the interaction between
LDL or mox-LDL and 5HT on cell number of VSMC
(Fig. 4). The results show that incubation of VSMC with
LDL or mox-LDL, or 5HT alone, produced an increase in
cell number compared with the baseline. When 5HT was
added to LDL or mox-LDL pretreated cells, there was a
further increase in the cell number.
Effect of 5HT2 receptor antagonist (LY281067) on syn-
ergistic interaction between LDL, mox-LDL and 5HT.
We examined whether a 5HT2 receptor antagonist would
inhibit the synergistic interaction between LDL, mox-LDL
and 5HT on cell proliferation response. In a previous report
(28) we have shown that LY281067, a 5HT2 receptor
antagonist, completely blocked the 5HT induced 3H-
thymidine incorporation without any cytotoxic effect. In this
study, VSMCs were incubated with LDL or mox-LDL for
24 h and then 10 mg/ml of LY281067 was added to the
media. Four hours after the addition of LY281067, 50 mM
Figure 2. Effect of 5HT on VSMC preincubated with LDL.
Synchronized VSMCs were stimulated without or with different
concentrations of LDL. After 24 h of incubation, indicated
concentration of 5HT was added and incubated for an additional
24 h. One hundred percent equals the baseline value for 3H-
thymidine incorporation into DNA (254 6 21 cpm). Values
shown are mean 6 standard error. 5HT 5 serotonin. All other
abbreviations as in Figure 1. n 5 24; *p , 0.01 compared with
corresponding control; **p , 0.01 compared with corresponding
lipoprotein group.
Figure 3. Effect of 5HT on VSMC preincubated with mox-LDL.
Synchronized VSMCs were stimulated with different concentra-
tions of mox-LDL. After 24 h of incubation, indicated concen-
tration of 5HT was added and incubated for an additional 24 h.
One hundred percent equals the baseline value for 3H-thymidine
incorporation into DNA (280 6 19 cpm). Values shown are
mean 6 standard error. Abbreviations as in Figure 2. n 5 24; *p ,
0.01 compared with corresponding control; **p , 0.01 compared
with corresponding lipoprotein group.
Figure 4. Effect of LDL or mox-LDL and 5HT on cell number.
Vascular smooth muscle cells (5 3 104) were plated in 2 mL of
serum free medium. After synchronization, vascular smooth mus-
cle cells were stimulated with different concentrations of LDL or
mox-LDL for 24 h, followed by incubation with 50 mmol/L of
5HT for 24 h. Then cells were trypsinized and counted as
described in the Materials and Methods section. Data represent
the mean 6 SE from triplicate dishes from three different
experiments. Baseline value is 256, 650 6 13, 430 cells/plate.
Abbreviations as in Figure 2. n 5 12. *p , 0.01 compared with
control; **p , 0.05 compared with corresponding control.
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5HT was added, and 24 h later 3H-thymidine incorporation
was measured. At 10 mg/ml, LY281067 blocked only the
proliferative effect of 5HT and its synergistic interaction
with LDL or mox-LDL but not the mitogenic effect of
LDL or mox-LDL (Fig. 5).
Effect of pertussis toxin (PTX) on synergistic interaction
between LDL, mox-LDL and 5HT. To distinguish be-
tween the proliferative mechanisms of 5HT and LDL or
mox-LDL, specific inhibitors of signal transduction path-
ways were used. Pertussis toxin, which ADP-ribosylates and
inactivates susceptible Gi-subclass of G proteins, at a
concentration of 10 ng/mL abolished the mitogenic effect of
5HT and its synergistic interaction with LDL and mox-
LDL (Fig. 6). Pertussis toxin itself was not cytotoxic to the
cells at the concentrations tested (data not shown). In
contrast, PTX at the concentration of 10 ng/mL did not
prevent the LDL or mox-LDL induced VSMC prolifera-
tion (Fig. 6).
Effect of polyinosinic acid (poly-I) on synergistic inter-
action between LDL, mox-LDL and 5HT. To evaluate
the possible role of the scavenger receptor in the prolifera-
tive mechanisms of LDL or mox-LDL, poly-I, which binds
to scavenger receptors, was used (37). Polyinosinic acid at
concentration of 25 mg/mL did not inhibit the mitogenic
effect of 5HT or LDL or mox-LDL (Fig. 7). Polyinosinic
acid itself at this concentration was not cytotoxic to the cells
at the concentrations tested (data not shown).
Figure 5. Effect of 5HT2 receptor antagonist (LY281067) on
5HT induced proliferation of LDL or mox-LDL pretreated
VSMC. Synchronized VSMCs were stimulated with different
concentrations of LDL or mox-LDL. 10 mg/mL of LY281067
was added 4 h before the addition of 5HT. After 24 h of
incubation with LDL or mox-LDL, 50 mmol/L of 5HT was
added and incubated for an additional 24 h. 3H-thymidine (1
mCi/plate) was added during the last 5 h of incubation. One
hundred percent equals the baseline value for 3H-thymidine
incorporation into DNA (276 6 17 cpm). Values shown are
mean 6 standard error. Abbreviations as in Table 2. n 5 24; *p ,
0.05 compared with LDL group control; **p , 0.05 compared
with corresponding LDL and 5HT group; @p , 0.01 compared with
mox-LDL group control; &p , 0.001 compared with 5HT; $p ,
0.001 compared with corresponding mox-LDL and 5HT group.
Figure 6. Effect of pertussis toxin (PTX) on 5HT induced
proliferation of LDL or mox-LDL pretreated VSMC. Synchro-
nized VSMCs were stimulated with different concentrations of
LDL or mox-LDL in the presence or absence of 10 ng/mL of
PTX. After 24 h of incubation with LDL or mox-LDL, 50
mmol/L of 5HT was added and incubated for an additional 24 h.
One hundred percent equals the baseline value for 3H-thymidine
incorporation into DNA (257 6 21 cpm). Values shown are
mean 6 standard error. Abbreviations as in Figure 2. n 5 24; *p ,
0.05 compared with corresponding control; **p , 0.01 compared
with LDL and 5HT group; @p , 0.01 compared with mox-LDL
group control; &p , 0.001 compared with 5HT; $p , 0.001
compared with corresponding mox-LDL and 5HT group.
Figure 7. Effect of poly-I on lipoprotein and 5HT induced VSMC
proliferation. Synchronized VSMCs were stimulated with different
concentrations of LDL or mox-LDL in the presence or absence of
25 mg/mL of poly-I. After 24 h of incubation with LDL or
mox-LDL, 50 mmol/L of 5HT was added and incubated for an
additional 24 h. One hundred percent equals the baseline value for
3H-thymidine incorporation into DNA (274 6 18 cpm). Values
shown are mean 6 standard error. poly-I 5 polyinosinic acid. All
other abbreviations as in Figure 2. n 5 10; *p , 0.05 compared
with corresponding control; **p , 0.05 compared with corre-
sponding lipoprotein group.
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DISCUSSION
This study demonstrates an interaction between LDL or
mox-LDL and 5HT on proliferation of VSMCs. Poly-
inosinic acid did not inhibit the proliferative effect of
mox-LDL, suggesting that, unlike oxidized LDL, mox-
LDL may not be recognized by the scavenger receptors.
The LY281067 reversed only the mitogenic effect of 5HT
but not that of LDL or mox-LDL on VSMCs. In general,
5HT-mediated responses are known to be PTX sensitive,
which indicates that serotonergic receptors are coupled with
the Gi subfamily of the G proteins alpha-subunit which
catalyzes the hydrolysis of phosphoinositide biphosphate.
Similarly, PTX reversed the mitogenic effect of 5HT but
did not inhibit the effect of LDL or mox-LDL on VSMCs.
Effect of LDL and mox-LDL on VSMC proliferation.
The growth promoting effects of native or oxidized LDL on
VSMCs are conflicting (6 – 8,21,22,38 – 40). Although
LDL has been reported to be cytotoxic to VSMCs in some
studies (12), others report growth stimulatory effects of
LDL on VSMCs in combination with serum (4–6) or
lipoprotein-depleted serum (8,25). In the studies involving
serum containing media, lipoproteins may have potentiated
the effects of growth factors present in the serum. However,
others have reported that LDL itself is a mitogen for
vascular endothelial or VSMCs under serum-free medium
conditions (8,38). The discrepancies in the results may be
due to the source or the way SMCs were isolated. In this
study, we used explant-derived SMCs which may be phe-
notypically different from those isolated by enzymatic meth-
ods. As reported by others (10,13,14,41), in our study, both
LDL and mox-LDL exhibited a biphasic effect on VSMCs:
a proliferative effect at low concentrations (20–120 mg
protein/ml) and a cytotoxic effect at high doses (.200 mg
protein/ml). It has been demonstrated that VSMCs can
modify LDL in vitro. The increased mitogenic effect of
mox-LDL or oxidized LDL is attributed to the chemical
changes brought about by the oxidation processes to the
LDL components such as, generation of hydrogen peroxide
and conversion of phosphatydilcholine to lysophosphatidyl-
choline (Lyso-PC). During the early periods of oxidation,
there is a significant accumulation of peroxides and presum-
ably other reactive oxygen intermediates, whereas the
Lyso-PC levels are still relatively low. After 24 h of
oxidative stress, LDL contains large amounts of Lyso-PC
but only small amounts of reactive oxygen intermediates
(42). Extensive oxidation is also associated with the forma-
tion of several oxysterols (42). Though oxygen radicals are
generally considered cytotoxic (43,44), recent studies have
demonstrated that, at low concentrations, oxygen radicals
may affect several of the mechanisms involved in cell growth
(45). Like most of the growth factors, they induce intracel-
lular alkalization and active transcription of early response
genes (46–48). There is also evidence that intracellular
oxygen radicals play a direct role in regulation of gene
transcription (49,50). At lower concentrations, Lyso-PC
also acts as a mitogen for VSMC (51). The growth
inhibitory effect of mox-LDL at higher concentrations may
be due to the higher levels of reactive oxygen species,
Lyso-PC or cytotoxic concentrations of oxysterols, or com-
bination of all three. It is possible that some degree of
oxidation of LDL may have occurred in our experiments
due to incubation with VSMCs for 48 h. To exclude this,
we repeated the experiments in the presence of butylated
hydroxy toluene, vitamin E, vitamin C and N-acetyl cystine
and found that there was no change in the effect of LDL on
SMC proliferation (data not shown) indicating that the
mitogenic effect of LDL in this study was not due to mild
oxidation of LDL during culture.
Role of LDL receptors in mox-LDL induced VSMC
proliferation. The mechanism for the growth-promoting
activity of LDL or mox-LDL is unknown. New membrane
components, notably cholesterol and phospholipids, are
required for cell division. When cells are grown in serum-
free medium, LDL is internalized by the cell after it is
bound to the LDL receptor. Lysosomal degradation of this
internalized LDL provides the cell with unesterified cho-
lesterol for use in membrane synthesis. Conversely,
Bjorkerud suggested that the growth promoting effects were
specific for the lipoproteins (8). It is assumed that both the
protein and lipid components of lipoprotein are essential for
proliferation of VSMC (9,10). Previous studies suggest that
growth promoting effects of native LDL require the pres-
ence of LDL receptors. Because both LDL and mox-LDL
are taken up by LDL B/E receptors (41), it is possible that
LDL receptors of VSMCs may mediate the uptake of both
LDL and mox-LDL into VSMCs. Similarly, poly-I, which
binds to the alternate scavenger receptors, did not inhibit
the proliferative effect of LDL or mox-LDL.
Effect of mox-LDL and 5HT on VSMC proliferation.
Generally, serotonergic receptors are found to be coupled to
pertussis toxin sensitive G-proteins (26,52). In this study,
pertussis toxin could only reverse the mitogenic effect of
5HT and its synergistic effect with LDL without affecting
the mitogenic effect of LDL. Previous studies have indi-
cated that Lyso-PC mediated mitogen activated protein
kinase (MAP-kinase) stimulation is insensitive to PTX
(51). In this study PTX also failed to reverse the mitogenic
effect of mox-LDL indicating that mox-LDL mediated
mitogenic effects may not be mediated via the G1-Ras/Raf
pathway. A MAP-kinase independent pathway shown to be
activated by cellular stress, tumor necrosis factor and ultra-
violet light (a form of oxidative stress) is represented by
stress activated protein kinases, a newly described family of
serine/threonine kinases termed as c-Jun N-terminal
kinases/stress activated kinase (JNK/SAPK) (53–55). Like
mitogen activated protein kinases, JNK/SAPK have been
known to activate AP-1 (activator protein-1) inducing
activity through c-Jun (56,57). It has been recently reported
that both Lyso-PC and hydrogen peroxide, the major
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components of oxidized LDL, stimulate JNK (51,58).
Therefore, the activation of a MAP pathway by 5HT and
redoxisensitive or JNK/SAPK pathway by mox-LDL may
explain the synergistic interaction in our studies. Thus, at
sites of vascular injury, platelet derived 5HT may interact
with the mox-LDL in stimulating the VSMC proliferation.
Conclusions. In the formation of atherosclerotic plaques,
deposits of LDL in the artery wall and platelet aggregation
are important steps. Low density lipoprotein (23,30,32),
mox-LDL (33) and oxidized LDL (59) induce platelet
aggregation and increase the release of 5HT from platelets
(25,31–33). Seewald et al. (60) have demonstrated that
LDL and thrombin act synergistically, and we have dem-
onstrated that TXA2 and serotonin (28) act synergistically
in stimulating SMC proliferation. Thus, it is conceivable
that, in addition to other classical growth factors such as
platelet derived growth factor, 5HT alone or in combination
with LDL or mox-LDL may also contribute to the forma-
tion of plaque.
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